XNAS · MDXG
Quote not reported
MiMedx Group, Inc

MiMedx Group, Inc

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Not reported
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
MDXG
MiMedx Group, Inc
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for MDXG until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
Loading MDXG catalysts
About MiMedx Group, Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2007
Employees
808
Country
US

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Market cap
$622.4M
EPS
$-0.0600
Shares out
145.8M

MDXG overview

Veridion Score
Not reported
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MDXG.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MDXG Form 4 filings
Public disclosures

Congress activity in MDXG

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MDXG in the cached public ledger.

Federal contracts

MDXG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MDXG in this window.
Lobbying spend

MDXG lobbying filings, year to date.

Registered lobbying filings matched to MiMedx Group, Inc.

$120.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid
Filing
$30.0K
MIMEDX

ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)

May 18, 2026
Filing
$30.0K
MIMEDX

ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)

Feb 5, 2026
Filing
$20.0K
MIMEDX

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ

Jul 20, 2026
Loading news for MDXG
Analyst ratings
Sovereign unlock shows live analyst consensus for MDXG.
Options
Sovereign unlock shows live options positioning for MDXG.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.